WallStreetZen

NASDAQ: ILMN
Illumina Inc Earnings & Revenue

ILMN past earnings growth

How has ILMN's earnings growth performed historically?
Company
-34.21%
Industry
50.17%
Market
38.16%
ILMN's earnings have grown slower (7.03% per year) than the US Diagnostics & Research industry average (27.48%)
Performance
ILMN's earnings have grown slower (7.03% per year) than the US market average (19.7%)
Performance
ILMN's earnings growth is slowing down - its growth over the last year (-34.21%) is below its 5-year compound annual rate (7.03%)
Performance

ILMN past revenue growth

How has ILMN's revenue growth performed historically?
Company
-8.58%
Industry
35.23%
Market
20.21%
ILMN's revenue has grown slower (7.85% per year) than the US Diagnostics & Research industry average (19.65%)
Performance
ILMN's revenue has grown slower (7.85% per year) than the US market average (18.53%)
Performance
ILMN's revenue growth is slowing down - its growth over the last year (-8.58%) is below its 5-year compound annual rate (7.85%)
Performance

ILMN earnings and revenue history

Current Revenue
$3.2B
Current Earnings
$656.0M
Current Profit Margin
20.3%
ILMN's has demonstrated consistent long-term earnings growth over the past 10 years (343.56%)
Performance

ILMN Return on equity

Current Company
14.1%
Current Industry
8.4%
Current Market
49.8%
ILMN's Return on Equity (14.1%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

ILMN Return on assets

Current Company
8.9%
Current Industry
6.6%
Current Market
5.4%
ILMN is generating higher Return on Assets (8.9%) than the US Diagnostics & Research industry average (5.81%)
Performance

ILMN Return on capital employed

Current Company
14.27%
Current Industry
10.5%
ILMN's ability to generate Return on Capital (14.27%) has decreased compared to 3 years ago (25.01%)
Performance

ILMN earnings dates

Next earnings date
Apr 28, 2021

Illumina Earnings & Revenue FAQ

What were ILMN's earnings last quarter?

On Jan 27, 2021, Illumina (NASDAQ: ILMN) reported Q4 2020 earnings per share (EPS) of $1.76, up 8.64% year over year. Total Illumina earnings for the quarter were $257.00 million. In the same quarter last year, Illumina's earnings per share (EPS) was $1.62.

What was ILMN's earnings growth in the past year?

As of Q2 2021, Illumina's earnings has grown -34.21% year over year. This is 84.39 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 50.17%. Illumina's earnings in the past year totalled $656.00 million.

What is ILMN's earnings date?

Illumina's earnings date is Apr 28, 2021. Add ILMN to your watchlist to be reminded of ILMN's next earnings announcement.

What was ILMN's revenue last quarter?

On Jan 27, 2021, Illumina (NASDAQ: ILMN) reported Q4 2020 revenue of $953.00 million up 0.11% year over year. In the same quarter last year, Illumina's revenue was $952.00 million.

What was ILMN's revenue growth in the past year?

As of Q2 2021, Illumina's revenue has grown -8.58% year over year. This is 43.81 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 35.23%. Illumina's revenue in the past year totalled $3.24 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.